Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer

Colorectal cancer (CRC) was the third most common malignant cancer and the fourth leading cause of cancer-related deaths worldwide [1]. Despite the advancement in comprehensive treatment, the long-term survival of CRC patients remains unsatisfactory. More than 20% of CRC patients were diagnosed with distant metastasis at initial diagnosis [2]. The microsatellite instability (MSI) subtype of CRC accounts for approximately 15% of colorectal cancers and results from the accumulation of frameshift mutations in target gene caused by a failure of the mismatch repair system [3]. MSI CRCs exhibit proximal colonic location, increased lymphocytic infiltration, and poorer response to chemotherapeutic drugs, and are characterized by highly upregulated expression of various immunological checkpoints [4, 5].

Apoptosis inhibitor of macrophage (AIM) is a circulating protein of approximately 40 kDa and mainly produced by tissue-resident macrophages, including liver Kupffer cells and peritoneal macrophages [6]. AIM, a member of the scavenger receptor cysteine-rich superfamily, is discharged from a macrophage and circulates throughout the body to remove cellular debris [7]. Moreover, recent studies revealed that AIM plays key roles in lipid accumulation, acute kidney injury, acute myocardial infarction, acute lung injury, sepsis, hepatic fibrosis, and hepatocellular carcinoma [8‐15].

However, there are few studies to evaluate AIM levels in patients with MSI CRCs. Therefore, the aim of this study was to compare MSI status with AIM levels in patients with CRC.

The study included 430 CRC patients between January 2018 and December 2018. Of the 430 participants entered, 245 (57.0%) were men and 185 (43.0%) were women. The mean ages were 59.5 ± 9.9 and 59.2 ± 10.2 years, respectively.

The characteristics of CRC patients are summarized according to MSI status in Table 1. There were no significant differences in gender, smoking status, drinking status, and creatinine levels between the two groups. CRC patients with MSI-H were young and had higher BMI, WBC, platelet count, AIM levels, and lower CEA and haemoglobin levels, compared to the patients with MSS.

The association between clinicopathological features and MSI status in CRC patients is shown in Table 2. There were significantly positive correlations between MSI-H status and tumor location, tumor size, histological grade, lymphatic invasion, lymph node metastasis, clinical stage, and histological type. However, no correlations were found between MSI-H and T classification, and distant metastasis.

The median value of AIM was 6.8 μg/mL (range 3.6–12.3 μg/mL). ROC analysis was used to assess the optimal cutoff value for AIM was 6.3 for MSI-H phenotype (AUC = 0.715, 95% CI 0.645–0.783, p < 0.001) (Fig. 1). CRC patients were divided into two groups according to the cutoff level. Of the total of 430 patients, 199 patients (46.3%) were detected with AIM of less than or equal to 6.3 μg/mL, while there were 231 patients (53.7%) whose AIM levels were greater than 6.3 μg/mL. Correlations between AIM and clinicopathologic variables are presented in Table 3. There were significant differences in age, histological type, and MSI status. However, gender, BMI, smoking status, drinking status, WBC, haemoglobin, tumor size, tumor location, lymphatic invasion, venous invasion, T classification, lymph node metastasis, distant metastasis, and clinical stage in two groups did not show significant differences.

All CRC patients were classified into quartiles according to their AIM levels, including quartile 1 (Q1) ≤ 5.9 µg/mL, 5.9 µg/mL < quartile 2 (Q2) ≤ 6.5 µg/mL, 6.5 µg/mL < quartile 3 (Q3) ≤ 7.2 µg/mL, and quartile 4 (Q4) ≥ 7.3 µg/mL (Fig. 2). The percentages of patients with MSI-H in each group were 28.7%, 17.7%, 6.9% and 5.6%, respectively. The results showed that as the serum AIM levels increased, the percentage of patients with MSI-H reduced.

Logistic regression analysis was performed to evaluate the clinicopathological factors that were associated with MSI-H status. Fourteen variables, including gender, BMI, WBC, haemoglobin, platelet count, CEA, AIM, tumor size, tumor location, lymphatic invasion, histological grade, histological type, lymph node metastasis, and clinical stage, were entered into the original equation. The factors found to be significantly associated with MSI-H in the regression analysis included BMI, WBC, platelet count, AIM, tumor size, tumor location, histological type, and histological grade (Table 4). Notably, reduced AIM levels were associated with a higher risk of MSI-H phenotype after adjusting for other confounding variables.

It has been shown for the first time that AIM levels were significantly reduced in MSI-H CRC patients compared with those in MSS CRC patients. AIM levels were correlated with age, histological type, and MSI status. Moreover, AIM levels were independently associated with MSI-H phenotype.

Macrophages in tumor microenvironment play a vital role in tumor development, angiogenesis, and metastasis [16, 17]. Recent studies confirmed that macrophages modulates the immune response against pathogens and maintains tissue homeostasis in cancer [18]. The main chemokines secreted from cancer cells attract macrophage and promote the expansion and dissemination of cancer cells [19]. Many reports demonstrated that tumor associated macrophages (TAMs) are one of the key targets to improve the efficacy of immunotherapies as these cells can suppress the functions of CD8⁺ T and NK cells [20]. M2-like TAMs are thought to drive neoangiogenesis, suppress the adaptive immune response, and promote tumor cell proliferation, invasion, and metastasis [18]. High TAM density was associated with worse survival in oral cancer, breast cancer, gastric cancer, bladder cancer, and ovarian cancer [20]. However, high TAM density has a better survival in CRC patients with or without metastases [21‐23].

The exact mechanisms of AIM in MSI-H CRCs were currently unclear. AIM was recognized to have an apoptosis inhibitory function for macrophages, T cells, and natural killer T cells [24]. However, AIM had different effects in different cancers. AIM overexpression in myeloid cells led to the formation of lung adenocarcinoma in a transgenic mouse model [25]. However, AIM-deficient mice were highly susceptible to steatosis-associated the development of hepatocellular carcinoma [26]. The difference of AIM in different CRC subtypes supports the crucial roles that macrophages play on immune cells. AIM acts as a marker for phagocytes so that they can efficiently recognize and engulf the debris as their target [7]. Moreover, the phagocytic activities performed by the non-professional phagocytes contribute to the physiological tissue turnover or remodeling, leading to maintenance of the tissue homeostasis. AIM plays a crucial role in obesity-induced inflammation in white adipose tissue as characterized by decreased proinflammatory M1 macrophages but increased anti-inflammatory M2 macrophages [6]. A recent report revealed that glycogen synthase kinase 3 modulates obesity-induced visceral adipose tissue inflammation by inhibiting AIM production in macrophages [27].

Consistent to our results, previous studies showed that the CD8 T effector gene signature was significantly upregulated in MSI-H tumors compared with MSI-L/MSS tumors [28]. Moreover, a report demonstrated that CD8(+) cytotoxic T lymphocytes may lead to increased platelet destruction in immune thrombocytopenia [29].

In this study, we found that activated platelets are involved in different CRC subtypes. Therefore, investigating the mechanism of AIM involved in MSI-H CRCs may be helpful for guiding treatment strategy in different CRC subtypes.

Some limitations of the present study need to be acknowledged: First, the study was performed in a single hospital. Second, our data can not provide a mechanistic explanation for our findings. Third, the results cannot be generalized because the study included only Chinese patients.

AIM levels were decreased in MSI-H CRCs. Further mechanistic research was needed.